Recently Viewed
Clear AllToday’s Range
52 Week Range
Liquidity
Market cap
$20,005 Mln
Revenue (TTM)
$21,310 Mln
Net Profit (TTM)
$1,407 Mln
ROE
0.3 %
ROCE
-- %
P/E Ratio
14.7
P/B Ratio
4.6
Industry P/E
--
EV/EBITDA
6.7
Div. Yield
0 %
Debt to Equity
3.1
Book Value
$48
EPS
$16
Face value
--
Shares outstanding
86,963,000
CFO
$14,185.00 Mln
EBITDA
$27,724.00 Mln
Net Profit
$3,086.00 Mln
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Tenet Healthcare (THC)
| 2.3 | -13.3 | 4.2 | 58.8 | 54.5 | 29.9 | 22.6 |
|
BSE Sensex*
| -12.4 | -11.4 | -12.2 | -1.5 | 8.6 | 8.6 | 11.5 |
|
S&P Midcap 400
| 0.5 | -5.8 | 1.7 | 13.2 | 12.3 | 4.8 | 9.0 |
|
Company
|
2025
|
2024
|
2023
|
2022
|
2021
|
2020
|
2019
|
|---|---|---|---|---|---|---|---|
|
Tenet Healthcare (THC)
| 57.4 | 66.3 | 54.9 | -40.3 | 104.6 | 5.0 | 121.9 |
|
S&P Midcap 400
| 5.9 | 12.1 | 14.4 | -14.5 | 23.2 | 11.8 | 24.1 |
|
BSE Sensex
| 9.1 | 8.1 | 18.7 | 4.4 | 22.0 | 15.8 | 14.4 |
Is there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Company |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Tenet Healthcare (THC)
|
203.2 | 20,005.3 | 21,310.0 | 1,407.0 | 16.9 | 33.5 | 14.7 | 4.6 |
| 73.0 | 96,853.4 | 402,067.0 | 1,768.0 | 1.3 | 2.3 | 54.8 | 1.3 | |
| 148.8 | 10,075.5 | 13,643.1 | 746.8 | 14.1 | -281.8 | 15.8 | 21.6 | |
| 99.7 | 10,098.8 | 5,935.2 | 566.2 | 18.1 | 25.1 | 18.1 | 4.1 | |
| 502.1 | 119,183.9 | 75,600.0 | 6,784.0 | 16.0 | -159.1 | 18.8 | 293.4 | |
| 265.8 | 21,869.0 | 13,951.7 | 876.5 | 9.5 | 10.5 | 25.2 | 2.5 | |
| 197.8 | 26,624.2 | 2,306.1 | -208.2 | -11.2 | -14.3 | -- | 15.5 | |
| 195.2 | 22,215.1 | 11,035.0 | 992.0 | 13.2 | 14.2 | 22.8 | 3.1 | |
| 205.0 | 12,186.8 | 5,057.8 | 344.0 | 9.2 | 16.9 | 36 | 5.5 | |
| 189.6 | 11,754.3 | 17,364.8 | 1,488.8 | 12.2 | 21.4 | 8.3 | 1.6 |
Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care... services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies. The company also provides intensive and critical care, and/or coronary care units; cardiovascular, digestive disease, neurosciences, musculoskeletal, and obstetrics services; outpatient services, including physical therapy; tertiary care services, such as cardiothoracic surgery, complex spinal surgery, neonatal intensive care, and neurosurgery services; pediatric quaternary care services through heart, liver, and kidney transplants programs; and limb salvaging vascular procedure, acute level 1 trauma, intravascular stroke care, minimally invasive cardiac valve replacement, imaging technology, surgical robotic, and telemedicine access services. In addition, it offers a range of procedures and services comprising orthopedics, total joint replacement, and spinal and other musculoskeletal procedures; gastroenterology; pain management; otolaryngology; ophthalmology; and urology. Further, the company operates acute care and specialty hospitals, off-campus emergency departments, imaging centers, urgent care centers, and micro-hospitals, as well as ambulatory surgery centers and surgical hospitals. Tenet Healthcare Corporation was founded in 1967 and is headquartered in Dallas, Texas. Read more
Chairman & CEO
Dr. Saumya Sutaria M.D.
Chairman & CEO
Dr. Saumya Sutaria M.D.
Headquarters
Dallas, TX
Website
The share price of Tenet Healthcare Corporation (THC) is $203.21 (NYSE) as of 18-Mar-2026 16:02 EDT. Tenet Healthcare Corporation (THC) has given a return of 54.54% in the last 3 years.
The P/E ratio of Tenet Healthcare Corporation (THC) is 14.70 times as on 13-Mar-2026.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
|
2025
|
12.42
|
4.14
|
|
2024
|
3.78
|
2.90
|
|
2023
|
12.88
|
4.90
|
|
2022
|
12.63
|
4.54
|
|
2021
|
9.73
|
8.65
|
The 52-week high and low of Tenet Healthcare Corporation (THC) are Rs 247.21 and Rs 109.82 as of 19-Mar-2026.
Tenet Healthcare Corporation (THC) has a market capitalisation of $ 20,005 Mln as on 13-Mar-2026. As per SEBI classification, it is a Mid Cap company.
Before investing in Tenet Healthcare Corporation (THC), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.